Fly News Breaks for April 24, 2017
Apr 24, 2017 | 07:57 EDT
As previously reported, Credit Suisse downgraded Nexvet Biopharma (NVET) to Neutral from Outperform following its previously announced acquisition by Zoetis (ZTS) on April 13, currently pending regulatory approval.
News For NVET;ZTS From the Last 2 Days
There are no results for your query NVET;ZTS